H3K4(Me3) (1-20) is a histone H3 N-terminal peptide carrying trimethylation on Lys4, enabling epigenetic-binding and chromatin-interaction studies. The modification supports recognition by chromatin-associated domains. Its sequence facilitates structural mapping of regulatory motifs. Researchers use it to investigate histone–protein interactions.
CAT No: R1037
2. Implications of ligand-receptor binding kinetics on GLP-1R signalling
3. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More